Frazier Life Sciences Management as of Sept. 30, 2022
Portfolio Holdings for Frazier Life Sciences Management
Frazier Life Sciences Management holds 43 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Hillevax (HLVX) | 12.8 | $167M | 9.8M | 17.09 | |
| Arcutis Biotherapeutics (ARQT) | 12.8 | $166M | 8.7M | 19.11 | |
| Phathom Pharmaceuticals (PHAT) | 7.2 | $93M | 8.4M | 11.08 | |
| Chinook Therapeutics | 6.5 | $84M | 4.3M | 19.66 | |
| Syndax Pharmaceuticals (SNDX) | 6.3 | $82M | 3.4M | 24.03 | |
| Mirum Pharmaceuticals (MIRM) | 6.2 | $80M | 3.8M | 21.01 | |
| Krystal Biotech (KRYS) | 5.5 | $71M | 1.0M | 69.70 | |
| Rhythm Pharmaceuticals (RYTM) | 3.6 | $46M | 1.9M | 24.50 | |
| Imago Biosciences | 3.4 | $45M | 3.0M | 15.05 | |
| Vaxcyte (PCVX) | 2.9 | $37M | 1.5M | 24.00 | |
| Cogent Biosciences (COGT) | 2.4 | $31M | 2.1M | 14.92 | |
| Tarsus Pharmaceuticals (TARS) | 2.4 | $31M | 1.8M | 17.12 | |
| Allakos (ALLK) | 2.3 | $29M | 4.8M | 6.12 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.1 | $28M | 1.4M | 19.64 | |
| Tricida | 2.1 | $27M | 2.5M | 10.48 | |
| Anaptysbio Inc Common (ANAB) | 1.8 | $23M | 900k | 25.51 | |
| Kalvista Pharmaceuticals (KALV) | 1.8 | $23M | 1.6M | 14.51 | |
| Alpine Immune Sciences (ALPN) | 1.7 | $22M | 3.0M | 7.20 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.7 | $22M | 2.1M | 10.22 | |
| Frazier Lifesciences Acqu Unit 12/09/2025 | 1.2 | $15M | 1.5M | 10.15 | |
| Merus N V (MRUS) | 1.2 | $15M | 747k | 20.03 | |
| ACADIA Pharmaceuticals (ACAD) | 1.1 | $14M | 857k | 16.36 | |
| Replimune Group (REPL) | 1.1 | $14M | 806k | 17.27 | |
| Gritstone Oncology Ord (GRTS) | 1.0 | $14M | 5.2M | 2.57 | |
| Arvinas Ord (ARVN) | 1.0 | $13M | 285k | 44.49 | |
| Tyra Biosciences (TYRA) | 0.9 | $12M | 1.3M | 8.79 | |
| Intellia Therapeutics (NTLA) | 0.9 | $11M | 204k | 55.96 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.9 | $11M | 393k | 28.26 | |
| Sutro Biopharma (STRO) | 0.8 | $9.9M | 1.8M | 5.55 | |
| Gracell Biotechnologies Sponsored Ads | 0.7 | $9.3M | 2.9M | 3.22 | |
| Bluebird Bio (BLUE) | 0.7 | $9.1M | 1.4M | 6.33 | |
| Silence Therapeutics Ads (SLN) | 0.7 | $8.7M | 881k | 9.87 | |
| Trevi Therapeutics (TRVI) | 0.6 | $8.3M | 5.4M | 1.54 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.6 | $8.0M | 3.7M | 2.14 | |
| Aclaris Therapeutics (ACRS) | 0.5 | $6.4M | 408k | 15.74 | |
| Passage Bio (PASG) | 0.4 | $4.7M | 3.8M | 1.25 | |
| Immunovant (IMVT) | 0.3 | $3.3M | 586k | 5.58 | |
| Macrogenics (MGNX) | 0.2 | $2.4M | 702k | 3.46 | |
| Pardes Biosciences | 0.1 | $1.6M | 846k | 1.85 | |
| Essa Pharma Com New (EPIX) | 0.1 | $1.3M | 693k | 1.82 | |
| Molecular Templates | 0.1 | $1.0M | 1.4M | 0.75 | |
| Aptinyx | 0.1 | $693k | 1.9M | 0.37 | |
| Nabriva Therapeutics Shs New 2022 (NBRVF) | 0.0 | $35k | 17k | 2.06 |
